BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 4573354)

  • 21. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
    Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
    J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlative study of rubella antibody titre, basement zone antibody titre, and IgG content of sera of patients with bullous pemphigoid.
    Remy W; Bockendahl H; Antoniadis G
    Acta Derm Venereol; 1974; 54(6):449-51. PubMed ID: 4140659
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies of the antibodies in pemphigoid and pemphigus.
    Sams WM; Schur PH
    J Lab Clin Med; 1973 Aug; 82(2):249-54. PubMed ID: 4578690
    [No Abstract]   [Full Text] [Related]  

  • 24. [Develop of localized pemphigoid following radiation treatment (author's transl)].
    Ernst TM; Marsch WC
    Dermatologica; 1982 Feb; 164(2):73-81. PubMed ID: 7042412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of immunoglobulin G anti-glomerular basement membrane antibodies eluted from kidneys of patients with glomerulonephritis. II. IgG subtypes and in vitro complement fixation.
    McPhaul JJ; Dixon FJ
    J Immunol; 1971 Sep; 107(3):678-84. PubMed ID: 4999091
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunohistochemistry of ultraviolet-induced pemphigus and pemphigoid lesions.
    Cram DL; Fukuyama K
    Arch Dermatol; 1972 Dec; 106(6):819-24. PubMed ID: 4565226
    [No Abstract]   [Full Text] [Related]  

  • 27. The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation.
    Jordon RE; Schroeter AL; Good RA; Day NK
    Clin Immunol Immunopathol; 1975 Jan; 3(3):307-14. PubMed ID: 45850
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum from normal elderly individuals contains anti-basement membrane zone antibodies.
    Hachisuka H; Kurose K; Karashima T; Mori O; Maeyama Y
    Arch Dermatol; 1996 Oct; 132(10):1201-5. PubMed ID: 8859031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of elastase-like enzymes in various blistering diseases.
    Oikarinen A; Kiistala U; Uitto J
    Acta Derm Venereol; 1986; 66(1):1-5. PubMed ID: 2424207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune complexes in pemphigus and bullous pemphigoid.
    Ahmed AR; Moy RL; Chia D; Barnett EV
    Dermatologica; 1983; 166(4):175-80. PubMed ID: 6343146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between theoretical molecular weight and blister fluid/serum ratio of cytokines and five other molecules evaluated in patients with bullous pemphigoid.
    D'Auria L; Pimpinelli F; Ferraro C; D'Ambrogio G; Giacalone B; Bellocci M; Ameglio F
    J Biol Regul Homeost Agents; 1998; 12(3):76-80. PubMed ID: 9795835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased tryptase and myeloperoxidase levels in blister fluids of patients with bullous pemphigoid: correlations with cytokines, adhesion molecules and anti-basement membrane zone antibodies.
    D'Auria L; Pietravalle M; Cordiali-Fei P; Ameglio F
    Exp Dermatol; 2000 Apr; 9(2):131-7. PubMed ID: 10772387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative studies of immunofluorescent staining. 3. Comparison of different antigens in an indirect immunofluorescent staining system for human IgG using the basement zone antibodies of bullous pemphigoid.
    Wick G; Beutner EH
    Immunology; 1969 Feb; 16(2):149-56. PubMed ID: 4976938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
    Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
    Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of basement membrane zone antigens and C3 fragments in the blister fluid of bullous pemphigoid.
    Lohrisch I; Herrmann K; Haustein UF
    Br J Dermatol; 1980 Feb; 102(2):135-43. PubMed ID: 6992829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-1 levels in blister fluids of some skin diseases with blister formation.
    Imaizumi T; Nomura K; Hashimoto I; Sawada Y
    Clin Physiol Biochem; 1990; 8(4):179-83. PubMed ID: 2078919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bullous pemphigoid blister fluid stimulates eosinophil colony formation and activates eosinophils.
    Varigos GA; Morstyn G; Vadas MA
    Clin Exp Immunol; 1982 Dec; 50(3):555-62. PubMed ID: 6762270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of IgG-subclass antibody determinations in bullous pemphigoid.
    Kumar V; Valeski JE; Chorzelski TP; Jablonska S
    J Clin Lab Anal; 1996; 10(6):432-4. PubMed ID: 8951615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic lupus erythematosus. Studies of the antibodies bound to skin.
    Landry M; Sams WM
    J Clin Invest; 1973 Aug; 52(8):1871-80. PubMed ID: 4578295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.